Latest news and articles about فايزر from NEX English
Pfizer has announced the development of an innovative treatment for alopecia areata, an autoimmune condition that causes sudden hair loss. This new therapy represents a significant step in addressing a condition that affects many individuals worldwide.
Pfizer and BioNTech have announced the suspension of their COVID-19 vaccine study in the United States due to difficulties in recruiting participants. This decision comes at a critical time as countries strive to enhance vaccination campaigns against emerging variants.
A Belgian court has mandated Poland and Romania to acquire Pfizer's COVID-19 vaccines worth up to <strong>$2.2 billion</strong>. This ruling stems from the countries' obligations under previous agreements with the company.
A Belgian court has ruled that Poland and Romania must pay <strong>€1.9 billion</strong> (approximately <strong>$2.2 billion</strong>) to American pharmaceutical company Pfizer due to their refusal to accept COVID-19 vaccines during the pandemic. This ruling marks a significant victory for Pfizer in its efforts to enforce contractual agreements.
Pfizer announced it will request approval from the FDA for a Lyme disease vaccine, despite not meeting statistical goals in clinical trials. Lyme disease, transmitted by ticks, poses serious health risks, necessitating further research and analysis.